Concentra Group Holdings Parent, Inc. · NYSE:CON

Concentra Group Holdings Parent — Q4 2024 Earnings Presentation

20 slides from Concentra Group Holdings Parent's earnings presentation, Jan 22, 2025

  1. Slide 1: 4th Quarter and Year-End 2024 Preliminary Results & Acquisition of Nova Medical Centers

    4th Quarter and Year-End 2024 Preliminary Results & Acquisition of Nova Medical Centers January 22, 2025 & ©2024 Concentra Inc. All rights reserved.

  2. Slide 2: Disclaimer

    Disclaimer Forward-Looking Statements This presentation contains forward-looking statements that express the Company’s current opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not limited to, financial guid

  3. Slide 3: Concentra At-a-Glance

    Concentra At-a-Glance Concentra is the largest provider of occupational health services in the United States by number of locations1, with a mission of improving the health of America’s workforce, one patient at a time KEY STATISTICS ROBUST FINANCIALS 552 157 $1.9bn $377mm Occupational health Onsite

  4. Slide 4: 4th Quarter and Year-End 2024 Preliminary Results

    4 t h Q u a r t e r a n d Ye a r - E n d 2024 Pr eliminar y Results ©2025 Concentra Inc. All rights reserved.

  5. Slide 5: Preliminary Financial Update: Q4 2024 Performance

    Preliminary Financial Update: Q4 2024 Performance Q4 ’23 Q4 ’24 YoY (∆) • Number of locations grew 2.2% YoY to 709 total locations Facility Count (End of Period) • In the fourth quarter, we opened up three new Total Occupational Health Centers 544 552 +8 occupational health centers (one center in ea

  6. Slide 6: Preliminary Financial Update: 2024 Full-Year Performance

    Preliminary Financial Update: 2024 Full-Year Performance FY 2023 FY 2024 YoY (∆) • Number of locations grew 2.2% YoY to 709 total Facility Count (End of Period) locations Total Occupational Health Centers 544 552 +8 • During 2024, we acquired or built 9 new Total Onsite Health Clinics 150 157 +7 occ

  7. Slide 7: Nova Medical Centers Transaction Overview

    N ov a M e d i c a l C e n t e r s Tr a n s a c t i o n O ve r v i e w ©2025 Concentra Inc. All rights reserved.

  8. Slide 8: Acquisition of Nova Medical Centers Accelerates Our Scale, Density and Growth

    Acquisition of Nova Medical Centers Accelerates Our Scale, Density and Growth + Acquisition of a scaled industry leader in occupational health, also dedicated to Concentra’s mission of improving the health of America’s workforce, one patient at a time ©2025 Concentra Inc. All rights reserved. 8

  9. Slide 9: Key Transaction Terms

    Key Transaction Terms The acquisition and deal structure meet our strict investment criteria and established capital allocation strategy PURCHASE FINANCIAL FUNDING INTEGRATION TIMING PRICE IMPACT Signed definitive Transaction currently Expected to be Proven integration Expect to close by end agreeme

  10. Slide 10: Nova Medical Centers Overview

    Nova Medical Centers Overview Investment Highlights Nova Medical Centers is a pure-play occupational health provider that is One of the largest pure-play occupational health groups in the U.S. = seamless strategic fit for Concentra highly complementary to Concentra Highly complementary footprint, cr

  11. Slide 11: Nova Expands Concentra's Footprint In Highly Attractive States

    Nova Expands Concentra’s Footprint In Highly Attractive States By Filling Gaps In Existing Areas And Expanding Into New Geographies… 45 States with service offerings 14 Concentra Locations 14 Concentra Locations 4 Nova Locations 6 Nova Locations WI 11 Concentra Locations IN 4 Nova Locations TN GA 54

  12. Slide 12: Our Capital Allocation Priorities Remain The Same, And We Plan to Efficiently De-Lever Post Close

    Our Capital Allocation Priorities Remain The Same, And We Plan to Efficiently De-Lever Post Close Capital Allocation Strategy Net Leverage Pro Forma Liquidity (Net leverage as multiple of Adj. EBITDA1) ($ in millions) M&A and De Novos Strong pipeline + disciplined approach to $456 enhancing footprin

  13. Slide 13: Full-Year 2025 Guidance

    F u l l - Ye a r 2 0 2 5 Guidance ©2025 Concentra Inc. All rights reserved.

  14. Slide 14: 2025 Full-Year Guidance

    2025 Full-Year Guidance FY 2024 Actual1 FY 2025 Guidance2 YoY Growth (%) Total Revenue $1,900.2mm ~$2.1bn ~10.5% Adjusted EBITDA3 $376.9mm $410mm – $425mm ~10.8%5 Capital Expenditures $65.7mm $80mm – $90mm6 Net Leverage4 3.5x ~3.5x (1) Preliminary and unaudited; (2) Guidance includes financial resul

  15. Slide 15: Our Long-Term Financial Targets

    Our Long-Term Financial Targets Stable Revenue Consistent Robust Free Prudent Dividend Growth Profitability with Cash Flow2 Deleveraging Continued Generation Strategy Improvement Mid-to-High 20%+ >80% ~3.0x $0.0625 Single-digit growth Adjusted EBITDA Annual FCF Targeted net Cash dividend per margin1

  16. Slide 16: Appendix

    Appendix ©2025 Concentra Inc. All rights reserved.

  17. Slide 17: With the Addition of Nova Centers, We Continue to be Highly Diversified Across Geographies

    With the Addition of Nova Centers, We Continue to be Highly Diversified Across Geographies Geographic Mix1 PF Geographic Mix2 Texas California 16% 18% 552 Occupational Texas 10% 619 Occupational California 16% Health Centers Health Centers Florida 6% Florida 5% Pennsylvania 6% Pennsylvania Remaining

  18. Slide 18: Reconciliation of Q4 and Full-Year 2024 Net Income to Adjusted EBITDA and Revenue

    Reconciliation of Q4 and Full-Year 2024 Net Income to Adjusted EBITDA and Revenue Three Months Ended Dec. 31, Year Ended Dec. 31, 1 2024 20241 ($ in millions) Low High 2023 Low High 2023 Revenue $465.0 $465.0 $440.7 $1,900.2 $1,900.2 $1,838.1 Net Income Attributable to the Company $19.3 $21.3 $27.9

  19. Slide 19: Reconciliation of 2025 Full-Year Adjusted EBITDA Guidance

    Reconciliation of 2025 Full-Year Adjusted EBITDA Guidance Range ($ in millions) Low High Net Income Attributable to the Company $157 $168 Net Income Attributable to Non-Controlling Interests $6 $6 Net Income $163 $174 Income Tax Expense $54 $58 Interest Expense $111 $111 Stock Compensation Expense $

  20. Slide 20: Slide 20

Concentra Group Holdings Parent — Q4 2024 Earnings Presentation on 6ix